U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07076914) titled 'Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy' on July 03.

Brief Summary: A randomized controlled trial to assess the impact of prophylactic proton pump inhibitor use to improve esophagitis in lung cancer patients undergoing radiation. Patients will be randomized into a standard of care arm or the prophylactic proton pump (daily) arm.

Study Start Date: Oct. 02, 2025

Study Type: INTERVENTIONAL

Condition: Primary Lung Cancer Non Small Cell Lung Cancer Small Cell Lung Cancer

Intervention: DRUG: Experimental (Health Canada Approved Proton Pump Inhibitors)

The intervention uses a proton pu...